Chronic obstructive pulmonary disease.
Department of Thoracic Medicine, National Heart and Lung Institute, Imperial College School of Medicine, London, United Kingdom. p.j.barnes@ic.ac.uk
P J
PJ
Barnes
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D010450:Endopeptidases / Q000378:metabolism; D006801:Humans; D007249:Inflammation; D019272:Leukocyte Elastase / Q000037:antagonists & inhibitors / Q000378:metabolism; D008173:Lung Diseases, Obstructive / Q000453:epidemiology / Q000235:genetics / Q000503:physiopathology / Q000628:therapy; D018384:Oxidative Stress; D010102:Oxygen Inhalation Therapy; D012307:Risk Factors; D016540:Smoking Cessation / Q000379:methods
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D010450:Endopeptidases; D019272:Leukocyte Elastase